a sublethal i.d. dose of LVS 4 to 14 days earlier, no overall increase in protection or change in the S. typhimurium LDo was observed. Thus, sublethal infection with LVS at skin sites induced rapid and specific protective immunity.
Francisella tularensis, the causative agent of tularemia, is tion are already cleared, typically weeks or months after the a facultative intracellular bacterium found predominantly in initial infection. Previously, we studied the expression of cold weather latitudes. Infection is usually initiated through protective immunity by challenging mice with a lethal dose skin, blood, or aerosol contact with infected rodents, result-of LVS 3 weeks after sublethal infection (10, 12, 22) . Mice ing in a potentially fatal ulceroglandular, respiratory, or that survived a sublethal inoculum of LVS i.d. or s.c. were typhoidal disease (41) . An attenuated vaccine strain is avail-resistant to lethal i.p., i.v., or i.d. challenge with LVS (10, able, although its success in preventing human disease in 12) by 3 weeks after sublethal priming. By this time, bacteria nature or in laboratory workers is variable (4, 43) , and the were usually no longer found in mouse tissues (9) . When we mechanisms responsible for development of protective im-tested the time course of development of protective immumunity to F. tularensis in humans are not well understood nity to LVS, we found that protection develops quite rapidly (41) . Our previous studies demonstrated that the live vaccine to an impressive degree: only 3 days after initiation of a strain (LVS) is pathogenic for laboratory mice when intro-sublethal i.d. infection with LVS, mice were able to survive duced intraperitoneally (i.p.), and causes a lethal infection a lethal i.p. LVS challenge of 10,000 LDss. This rapid that is quite similar to human disease (12); the mouse is thus generation of immunity is characterized in the present rean appropriate model for elucidating the nature of infection port. and immunity to F. tularensis. The i.p. or intravenous (i.v.) 50% lethal dose (LDo) in inbred mice is quite low, generally MATERIALS AND METHODS approaching a single bacterium. The LD 5 o when LVS is introduced into mice intradermally (i.d.) at the base of the Mice. Specific-pathogen-free male C3H/HeNHSD mice, 5 tail or subcutaneously (s.c.) in skin or in footpads, however, to 6 weeks of age, were purchased from Harlan Sprague is several orders of magnitude higher (10, 12) . The mecha-Dawley, Frederick, Md., and housed in barrier facilities until nisms responsible for this striking difference are the subject use at 7 to 10 weeks of age. Pathogen-free male C57BL/oJ of ongoing study. Since initial resistance to i.d. Francisella and BALB/cByJ mice were purchased from Jackson Laboinfection is completely dependent on tumor necrosis factor ratory, Bar Harbor, Maine. All mice were quarantined for 1 (TNF) and gamma interferon (IFN--y) production in the first week after transportation before use and were age matched 2 days after infection (22), the observation of a high LD,(o within an experiment. Sentinel mice were routinely screened after i.d. infection at least suggests that events in murine skin serologically for evidence of infection with a panel of mouse facilitate rapid activation of IFN-y-producing cells that are pathogens and were consistently found to be negative. required for both initial survival and clearance of bacteria.
Bacteria. F. tularensis LVS (ATCC 29684) was purchased Protective immunity to many pathogens is generally as-from American Type Culture Collection, Rockville, Md., , sessed at time points when organisms from the initial infec-and cultured in either supplemented Mueller-Hinton broth in a 37'C air shaker or on modified Mueller-Hinton agar plates in a humidified 37°C incubator with 5% CO (2, 12 Survival was monitored for 30 days, although most deaths occurred within 4 to 7 days after infection. The LD 5 1 under various experimental circumstances was determined by inoculation of groups of at least five mice with doses of and in the spleen after sublethal i.d. inoculation is shown in bacteria covering a 4-log range and calculated by the method Table 1 . Bacteria were found in the spleen within 1 day after of Reed and Muench (35,. i.d. inoculation with 104 LVS, and by day 3 after inoculation, Estimation of bacteria in organs. At various times after bacteria were observed In the peritoneum. Bacterial burdens infection with 104 LVS i.d., mice were euthanized by cervi-peaked by day 4 in both sites and began to decrease cal dislocation. Peritoneal fluid was recovered by injection of thereafter. Comparable results were observed when 10' 5 ml of sterile PBS into the exposed peritoneal cavity and bacteria, the other commonly used priming dose, were withdrawal of fluid; generally 3 to 4 ml of fluid was recov-inoculated i.d. (with correspondingly lower absolute numered. Spleens were removed aseptically and homogenized in bers of bacteria detected in organs [91). Thus, i.p. challenge 5 ml of sterile PBS. Cells from either source were lysed by with a lethal dose of 104 LVS on days 3 and after added the addition of sodium dodecyl sulfate (final concentration, bacterial numbers to a preexisting bacterial burden already 0.05%), and numbers of bacteria were determined by plate present in the peritoneum and elsewhere (12) as a result of counts of appropriately diluted samples of each tissue. the initial i.d. infection. Results are expressed as the mean CFU per organ for groups Magnitude of protection against lethal F. tularensis chalof three mice; standard errors are omitted for clarity but lenge administered by several routes. Mice were given 10' were generally less than 20%. LVS i.d. and challenged with lethal i.p., i.v., or i.d. doses of LVS 3 days later. The doses chosen were 4 logs, 3 logs, and 3 logs greater than the LD 5 1 for the i.p., i.v., and i.d. routes, RESULTS respectively (10, 12). As seen in Table 2 , all mice (five of Time course of development of protective immunity to F. five) succumbed to i.p., i.v., and i.d. infection when control tu/arensis. To characterize the time course of development of diluent PBS was used for priming 3 days previously. The protective immunity, we inoculated mice with a sublethal dose (10"f) of LVS i.d. (priming); initial dose response studies established that primin,; with sublethal doses of LVS i.d. alive for greater than 30 days. Surprisingly, 75% of mice challenged on day 2 survived lethal i.p. challenge, and 100% of mice challenged on days 3 and 7 survived ( Fig. 1 ).
C3H/HeN mice were inoculated i.d. with l01 LVS. On the indicated days thereafter, three mice per time point were sacrificed; peritoneal fluid and cells Substantial protective immunity was thus expressed quite wer, nhitinerd by la,.p.c with ' ml oit sterile PHS, and spleens were rapidly after sublethal inoculation with LVS, at a point when homogenized in 5 ml of sterile PBS. Serial dilutions of aliquots of each were appreciable numbers of bacteria (on the order of 105 bacteria plated as described in Materials and Methods. Numbers of CFLU were per spleen or liver; see reference 12) were still present in adjusted to a total for each site; results shown are the mean ('FL) per site for groups (of three mice. This experiment is representative of two experiments of mouse tissues from the initial inoculation (9, 12) . similar design, both of which had comparable results.
The extent of bacterial dissemination in the peritoneum I limit of detection of assay was 10 colonies per organ. Table 4 ). The previously increased the i.p. LD 5 0 to 3 X 106 bacteria ( (10) . Similarly, short-term LVS at any skin-related site. (3-day) priming resulted in a substantial shift in the i.v. LDo, Specificity of rapid generation of protective immunity to F. to 5 x 106 in C3H/HeN mice and 8 x 106 in C57BL/6J mice tularensis. The rapid expression of protective immunity, (Table 3 ). By comparison, the i.v. LD 5 o in C3H/HeN mice demonstrable only 2 days after priming, occurred before primed 3 weeks previously with LVS is 9 x 106 (10). Thus, detectable levels of specific antibody appeared in the serum most of the increase in the i.p. or i.v. LDso that occurred of infected mice (36) , and too quickly to be attributed to after i.d. priming took place within the first 3 days after activation and response of conventional T cells. The possiinitial i.d. infection with LVS.
bility that this protection was not specific for LVS was tested Skin-related induction of immunity to F. tularensis. The with several different bacterial pathogens. Mice were primed generation of long-term immunity to LVS is not limited to with a sublethal (10-) dose of LVS i.d. and challenged at i.d. inoculation of LVS at the base of the tail, since mice can various times after infection with lethal doses i.p. of either be primed to resist lethal challenge 3 weeks later by intro-LVS (104, 10,000 LD 5 o) or E. coli BORT (107; 50 LD,,s). ducing LVS s.c. at other skin sites, such as in the flank or in While 100% of challenged mice survived lethal LVS infecthe footpad (10) . This was also true for the rapid generation tion initiated on day 2 after priming and at all subsequent of immunity, as shown in Table 4 . Mice were primed i.v. time points, none of the mice reproducibly survived lethal E. coli challenge (Fig. 2) . There was no effect of LVS priming on the mean time to death of mice that died from E. coli greater LVS-primed mice survived lethal challenge, while no BCG-primed mice survived (Fig. 3) . Thus, protective immunity to LVS was not generated by infection with this dose of lethal W118 challenge. The only measurable influence on BCG, which is sufficient to prime mice for in vitro lympho-W118 infection was an increase in the mean time to death kine production (29, 37). Since BCG is not virulent for mice, (Fig. 4 ) from about 4 days in unprimed mice to a maximum a reciprocal challenge experiment testing immunity to lethal of about 14 days in mice primed 4 to 7 days previously with BCG challenge after LVS priming was not possible.
LVS i.d. This increase waned with time; by day 21 after S. typhimurium W118 is a gram-negative intracellular sublethal i.d. LVS infection, the mean time to death from bacterium that, like LVS, has an i.p. LDo of a single
Salmonella infection was about 6 days. Sublethal i.d. infecbacterium in susceptible BALB/c mice (19, 32) . Mice were tion with W118 did not reliably lead to protection against primed with a sublethal (10") dose of LVS i.d. and chal-lethal Salmonella challenge, and therefore the reciprocal lenged at various times thereafter with a lethal (103) i.p. dose experiment was not interpretable. of either LVS or W118 (1,000 LD,, 1 
s in both cases). As seen
This subtle influence on the mean time to death from in Fig. 4 , by day 2 after i.d. infection, all mice could Salmonella infection after LVS priming suggested that some withstand lethal LVS challenge, but none could survive nonspecific resistance was generated but that it was insufficient to permit survival of a 1,000-LD 511 lethal challenge. We therefore tesied the effect on the actual W118 i.p. LDSf on day 4 after sublethal LVS priming i.d., a time when LVS 100 priming resulted in the maximal increase in mean time to 1o0death from Salmonella infection (Fig. 4) . In unprimed C3HI 80 I HeN mice, the i.p. LD 5 , 1 for W118 was 3 x 102, while in mice primed days previously with 10-LVS i.d., the Salmonella "60i.p.
LD. 1 was 1 x 103. Conversely, there was no difference between the LVS i.p. LDn_ values determined in unprimed 40 mice (one bacterium) and mice primed with a sublethal dose I of W118 i.d. 3 days earlier (three bacteria). 20 Thus, there was no effect from E. coli or BCG priming on lethal LVS infection nor from LVS priming on lethal E. coli 0 1 infection is initiated by skin-related routes (i.d. or s~c. 110, secuete many cytokines, including IFN--y, upon in vitro 12, 221). This disparity may have a correlate in the course of stimulation (29, 37) . Despite probable T-cell activation and wild-type human Francisella infection: tularemia is esti-cytokine production in vivo, however, inoculation of BCG mated to be fatal in only 5% of untreated cases when the i.d. had no effect on survival of LVS infection. route of entry is the skin, but may approach 60c/c when Both Listeria (3, 7, 15, 30, 46) and Salmonella (17, 19, infection is initiated by aerosol (40) . Further, sublethal 25-28, 30), 44, 47) infections have an early, T-cell-indepeninfection with LVS in mice leads to the development of dent phase that limits bacterial replication and a later, significant protective immunity: animals given either i.d. or T-cell-dependent phase that results in actual bacterial clears.c. LVS are able to withstand lethal i.p. or i.v. challenges 4
ance. Both IFN-y and TNF appear to play an important role to 7 logs higher than the LD,, in naive mice (10, 12) . Our in early resistance to Salmonella (25, 26, 28, 38, 44, 45) and previous studies concentrated on the characterization of this Listeria (3, 7, 46) infection, and the IFN--y in both cases may immunity at 3 weeks after i.d. infection, a time when be derived from a non-T NK cell (3, 7. 38, 46) . Thus, bacteria are usually cleared from organs. Here we document nonspecific cross-protection between Listeria and Salmothat this protective immunity develops quite rapidly and well nella cells is predictable, and indeed about 50% of the mice before bacterial clearance: within 2 days after sublethal i.d.
infected with the aro avirulent SL3235 Salmonella strain can LVS infection. virtually all mice were able to survive enor-survive 10 to 100 LD,,s of Listefia infectioin (19). Nonspemous lethal i.p., i.v., or even i.d. challenges. As observed cific protection against L. monocytogenes was noted by day with other bacteria such as S. typhimurium (8, 16) , i.d. 3 after Salmonella infection that appeared to peak by day 6 infection with live bacteria was far more successful at and wane within 1 month (19, 47) . Similar to the results for generating immunity than inoculation with the same num-LVS reported here, substantial specific protection against bers of heat-killed bacteria (Table 4 ). Further, sublethal i.v.
homologous Salmonella challenge was also demonstrable infection was unable to generate substantial immunity within within 3 days after Salmonella priming; this early protective 3 days, although comparable numbers of bacteria introduced activity was attributed to macrophage-like adherent cells i.d. were able to generate immunity (Table 4) ; however, it is (but not T cells) that could be detected by passive transfer possible that i.v. inoculation results in relatively more inac-experiments (19). tivation of injected bacteria than i.d. inoculation. Taken
In the present study, the possibility of nonspecific crosstogether, these observations suggest that live infection at protection between LVS and S. typhimurium was studied skin sites is especially efficient in the rapid generation of carefully, since infections with S. typhimunium and F. tulaprotective immunity.
rensis are quite similar in many respects. Both are gram-Since substantial numbers of bacteria have already dis-negative facultative intracellular organisms that have a very seminated to the peritoneum and the spleen within 3 days of low LD,,, for mice when introduced i.p. and a higher LDS, i.d. inoculation (Table 1 ) (12), infection in the skin has when introduced i.d. (9, 10, 12) . IFN--y and TNF probably apparently activated mechanisms that permitted survival not play important roles in early resistance to infection with both only of the initial bacteria burden, but also of the secondary (22, 25, 26, 28, 44) . Salmonella infection in mice is, however, introduction of even greater numbers of bacteria. The differ-under control of at least four genes in the mouse (ity, lps,xid, ence between i.p. or i.v. LD 5 os with and without priming and another unidentified gene in C3HeB/FeJ mice [331), measured here (Table 3) is therefore an underestimation of while obvious genetic control is not a feature of Francisella the bacterial burdens which i.d.-primed mice can withstand, infection. In the present study, sublethal infection with LVS The rapid development of protective immunity occurred had no effect on survival after challenge with 1,000 LD,,s of before specific antibody to LVS is detected in serum (36) and S. typhimurium W118 in Salmonella-susceptible (ity') mice before specific T-cell expansion is usually detected (25, 31). (Fig. 4) , and in fact had only a very small effect when the i.p. The 2-to 3-day interval necessary between priming and Salmonella LDo was measured 3 days after sublethal LVS survival of challenge corresponds exactly, however, to the infection in resistant (ity,) mice (see Results) or in susceptitime course of tumor necrosis factor (TNF) and IFN-y ble BALB/cByJ mice (9) . Conversely, Salmonella infection production after i.d. LVS infection (22). Thus, using inocu-had no effect on the magnitude of the i.p. LVS LDR 1 (see lations of anti-TNF and anti-IFN--y monoclonal antibody to Results). The only evidence for nonspecific cross-protection deplete cytokines in vivo, we demonstrated previously that that we observed was a transient increase in mean time to TNF and IFN--y must be available within the first 2 days after death from Salmonella infection in mice infected 3 to 14 days i.d. inoculation of LVS for mice to survive and clear bacteria previously with a sublethal dose of LVS. These increases in (22). It seemed likely, therefore, that the early activation of mean time to death were also noted in the LD 5 , 1 studies, but cytokine production might also be responsible for the ob-no long-term effect on survival was observed. Taken toserved rapid development of protection. The effects of such gether, all these results indicate that the rapid generation of cytokine production might further be nonspecific and lead to systemic protective immunity to LVS after sublethal infecprotection against other bacteria in which TNF and/or IFN-y tion is indeed specific for LVS itself. play a protective role.
As already mentioned, the rapid generation of protective This prediction was not substantiated by the results pre-immunity to LVS after sublethal priming is not consistent sented here, however. In E. coli BORT infection, TNF is with the usual time requirements for activation, clonal produced early after infection and has a beneficial role in expansion, and cytokine production by conventional T cells. protection against disease (5) . Sublethal E. coli infection had lKtead, we suggest that skin-rclated infection (39) may lead no effect on survival after LVS infection, however (Fig. 2) .
to efficient and rapid activation of keratinocytes (1, 20). y-y1* Further, BCG infection s.c. in footpads and in the skin dendritic epithelial T cells (42), and/or NK cells (13. 23). induces antigen-responsive a/l (14) and "y/1 (18) T cells in the Keratinocytes can produce TNF (20), while dendritic epithcdraining lymph nodes of infected mice. Mycobacteria-re-lial T cells (42), NK cells (13, 23). and human peripheral -y/8 sponsiveTcells produce interleukin2(18)invivoand IFN--y T cells (11) have the capacity to produce IFN--y when at least in vitro (6, 11, 34) . Spleens removed from mice stimulated by bacteria. In fact, in vivo depiction of y'; T primed with the dose and lot of BCG used here readily cells exaggerates early Listeria infection (15). and in vivo ivTr.~ 
